Bristol-Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Capital expenditures increased by 5% from FY24 to FY25.
Current Price
$58.22
-3.91%GoodMoat Value
$98.93
69.9% undervaluedBristol-Myers Squibb Company (BMY) Insider Trades
BMY Insider Trading Activity
Track insider trading transactions for Bristol-Myers Squibb Company (BMY). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.
Current stock price: $58.22. Market cap: $118.56B. This page displays the most recent insider transactions for BMY, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.
Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Bristol-Myers Squibb Company's investment outlook.